DK2268287T3 - Doseringssystemer af et antitumormiddel, omfattende deoxycytidinderivat - Google Patents

Doseringssystemer af et antitumormiddel, omfattende deoxycytidinderivat

Info

Publication number
DK2268287T3
DK2268287T3 DK09738900.1T DK09738900T DK2268287T3 DK 2268287 T3 DK2268287 T3 DK 2268287T3 DK 09738900 T DK09738900 T DK 09738900T DK 2268287 T3 DK2268287 T3 DK 2268287T3
Authority
DK
Denmark
Prior art keywords
deoxycytide
antitumum
ingredient
agent
dosage systems
Prior art date
Application number
DK09738900.1T
Other languages
English (en)
Inventor
Hiroyuki Okabe
Kazuhito Arakawa
Original Assignee
Delta Fly Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delta Fly Pharma Inc filed Critical Delta Fly Pharma Inc
Application granted granted Critical
Publication of DK2268287T3 publication Critical patent/DK2268287T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK09738900.1T 2008-04-29 2009-04-28 Doseringssystemer af et antitumormiddel, omfattende deoxycytidinderivat DK2268287T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/111,369 US7863255B2 (en) 2008-04-29 2008-04-29 Methods of administering antitumor agent comprising deoxycytidine derivative
PCT/JP2009/058725 WO2009133963A1 (en) 2008-04-29 2009-04-28 Methods of administering antitumor agent comprising deoxycytidine derivative

Publications (1)

Publication Number Publication Date
DK2268287T3 true DK2268287T3 (da) 2014-06-02

Family

ID=41050984

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09738900.1T DK2268287T3 (da) 2008-04-29 2009-04-28 Doseringssystemer af et antitumormiddel, omfattende deoxycytidinderivat

Country Status (8)

Country Link
US (1) US7863255B2 (da)
EP (1) EP2268287B1 (da)
JP (1) JP5570429B2 (da)
AU (1) AU2009240908B2 (da)
DK (1) DK2268287T3 (da)
ES (1) ES2467968T3 (da)
PL (1) PL2268287T3 (da)
WO (1) WO2009133963A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0625283D0 (en) 2006-12-19 2007-01-24 Cyclacel Ltd Combination
JP2014001204A (ja) * 2012-05-23 2014-01-09 Kumamoto Univ 腫瘍細胞選択的抗がん剤
WO2022014025A1 (ja) 2020-07-17 2022-01-20 Ｄｅｌｔａ－Ｆｌｙ Ｐｈａｒｍａ株式会社 血液がんの新規治療法及び新規治療剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2559917B2 (ja) 1990-06-15 1996-12-04 三共株式会社 ピリミジンヌクレオシド誘導体
GB0328180D0 (en) * 2003-12-04 2004-01-07 Cyclacel Ltd Combination
GB0609530D0 (en) * 2006-05-12 2006-06-21 Cyclacel Ltd Combination

Also Published As

Publication number Publication date
AU2009240908B2 (en) 2013-10-03
US7863255B2 (en) 2011-01-04
EP2268287A1 (en) 2011-01-05
JP5570429B2 (ja) 2014-08-13
EP2268287B1 (en) 2014-05-21
WO2009133963A1 (en) 2009-11-05
JP2011518761A (ja) 2011-06-30
PL2268287T3 (pl) 2014-10-31
ES2467968T3 (es) 2014-06-13
AU2009240908A1 (en) 2009-11-05
US20090270340A1 (en) 2009-10-29

Similar Documents

Publication Publication Date Title
CY2020014I2 (el) Σχημα δοσολογιας ενος αγωνιστη υποδοχεα s1p
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BRPI0910503A2 (pt) compostos, composições farmacêuticas e respectivos usos.
BRPI0918360A2 (pt) composto, composição farmacêutica e usos de um composto
DK3395372T3 (da) System til afgivelse af glutathion-baseret medikament
DK2117521T3 (da) Transdermale indgivelsessystemer omfattende bupivacain
BRPI1007018A2 (pt) composto, composição farmacêutica, e , uso de um composto.
DK2173407T3 (da) Anordning til indgivelse af lægemiddel
DK3473093T3 (da) Biomimetisk vaskulært netværk
BRPI1010772A2 (pt) composto,e, composição farmacêutica.
BRPI1008906A2 (pt) composto, composição farmacêutica, e, uso de um composto.
BR112013008259A2 (pt) composto, composição farmacêutica, e, uso de um composto
DK2462116T3 (da) Fremgangsmåde til fremstillingen af farmaceutisk aktive forbindelser
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
DK2408446T3 (da) Anvendelse af farmaceutiske sammensætninger, der indeholder mesembrenon
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
DK2367542T3 (da) Orale doseringsformer af bendamustin
BRPI0921654A2 (pt) formulação farmacêutica
BRPI0912428A2 (pt) formulação farmacêutica sólida de liberação retardada
DK2271618T3 (da) Farmaceutiske forbindelser
DK2131818T3 (da) Ny doseringsform